Stock analysis searches answered, part 26 of 43

Cleantech lithium plc bullish and bearish analyst opinions

Read from its name, “Cleantech lithium plc” is a the United Kingdom entity — “plc” is the UK public limited company form, so the company’s accounts are filed at Companies House. Its accounts and exchange notices are published through Companies House and the London Stock Exchange RNS announcements (find-and-update.company-information.service.gov.uk); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Cleantech lithium plc bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Cleantech lithium plc” appears in 48 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “cleantech” (search terms considered: cleantech, lithium).

The wording suggests a business based in the United Kingdom. Companies there file with the London Stock Exchange and the FCA National Storage Mechanism rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “cleantech” is therefore the the United Kingdom regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 48 most relevant full-text hits returned for “Cleantech lithium plc”, filings range from 2023-05-30 to 2025-08-25. The filers whose documents mention it most often are SPROTT FUNDS TRUST (CIK 0001728683) (47 hits); Fraser Mackenzie Accelerator Corp. (CIK 0001962622) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 46 entities whose registered name contains the word “cleantech”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “cleantech” 46, “lithium” 89. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “cleantech” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Clinuvel pharmaceuticals ltd. bullish and bearish analyst opinions

For “Clinuvel pharmaceuticals ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Clinuvel Pharmaceuticals Ltd, which trades as CUVL, CLVLF and files under Central Index Key 1290877. EDGAR puts it in the “American Depositary Receipts” industry code with Australia as its state or country of incorporation; its earlier registered name was EpiTan LTD. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-15, across 47 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on Clinuvel Pharmaceuticals Ltd (CIK 1290877) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 14 8-K or 6-K reports in Clinuvel Pharmaceuticals Ltd’s recent EDGAR index, the 4 listed here run from 2026-10-01 to 2026-10-15, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 47 recent EDGAR filings, Clinuvel Pharmaceuticals Ltd most often filed 6-K (14), SUPPL (6), CORRESP (4), UPLOAD (4). A selection from 2026-07-09 to 2026-07-17:

The full record for CIK 1290877 is on the EDGAR company page and the oldest filing in the recent index dates from 2004-05-07. Insider trades for Clinuvel Pharmaceuticals Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cnfinance holdings limited bullish and bearish analyst opinions

For “Cnfinance holdings limited bullish and bearish analyst opinions”, the matching SEC registrant is CNFinance Holdings Ltd., which trades as CNF and files under Central Index Key 1733868. EDGAR puts it in the “Finance Services” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-08-28, across 163 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-30 by CNFinance Holdings Ltd. (CIK 1733868) — source document:

Operating and Financial Review and Prospects 100 5.A. Operating Results 100 5.B. Liquidity and Capital Resources 127 5.C. Research and Development 132 5.D. Trend Information 132 5.E. Critical Accounting Estimates 132 Item 6. Directors, Senior Management and Employees 133 6.A. Directors and Senior Management 133 6.B. Compensation 134 6.C. Board Practices 137 Item 7. Major Shareholders and Related Party Transactions 143 7.A. Major Shareholders 143 7.B. Related Party Transactions 143 7.C. Interests of Experts and Counsel 143 Item 8. Financial Information 144 8.A. Consolidated Statements and Other Financial Information 144 8.B. Significant Changes 144 Item 9. The Offer And Listing 145 9.A. Offering and Listing Details 145 9.B. Plan of Distribution 145 9.C. Markets 145 9.D. Selling Shareholders 145 9.E. Dilution 145 9.F. Expenses of the Issue 145 i Item 10.

Financial trend for CNFinance Holdings Ltd. from annual reports, periods 2022-12-31 to 2025-12-31: revenue was tagged only for 2022-12-31 at 1,731,352,575 CNY; net income (loss) was tagged only for 2022-12-31 at 135,351,411 CNY; total assets went from 14,481,919,900 CNY (2022-12-31) to 10,249,119,696 CNY (2025-12-31), a change of -29.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1733868, tags Assets, InterestAndDividendIncomeOperating, NetIncomeLoss; 4 periods shown, dashes mark figures CNFinance Holdings Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on CNFinance Holdings Ltd. (CIK 1733868) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 50 8-K or 6-K reports in CNFinance Holdings Ltd.’s recent EDGAR index, the 4 listed here run from 2026-02-12 to 2026-08-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1733868 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2018-03-29. Insider trades for CNFinance Holdings Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Commonwealth fusion systems arc virginia progress 2026

For “Commonwealth fusion systems arc virginia progress 2026”, the matching SEC registrant is Commonwealth Fusion Systems LLC, which trades as none listed and files under Central Index Key 1744079. EDGAR puts it in the “no SIC description” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a D filed 2021-12-02, across 4 filings on record. This is reference material, not trading advice.

For the latest news, the fastest official source is the filing feed: Commonwealth Fusion Systems LLC (CIK 1744079) filed 0 current reports (8-K or 6-K) in its recent EDGAR window, and its overall latest filing is a D dated 2021-12-02. Companies must file an 8-K within four business days of most material events.

What kind of filer this is matters for “Commonwealth fusion systems arc virginia progress 2026”: Commonwealth Fusion Systems LLC’s EDGAR record from 2018-06-27 to 2021-12-02 consists only of D/A filings; Form D notices of exempt private offerings, which means it raised money privately rather than registering shares for public trading. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

The full record for CIK 1744079 is on the EDGAR company page and the oldest filing in the recent index dates from 2018-06-27. Insider trades for Commonwealth Fusion Systems LLC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Progress on ARC in 2026 is reported by the company itself and by Virginia state and Chesterfield County economic-development announcements, not through periodic SEC reports, because Commonwealth Fusion Systems is privately held. The only EDGAR trail is its Form D notices of exempt securities offerings, which record that capital was raised but say nothing about construction milestones, permits or a target date for first power.

Cti logistics limited bullish and bearish analyst opinions

“Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. The name “Cti logistics limited” therefore points to a company organised in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), and its official disclosures are on that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk), not on EDGAR.

No SEC filer could be matched to “Cti logistics limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Cti logistics limited” appears in 2 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “cti” (search terms considered: cti, logistics).

In the 2 most relevant full-text hits returned for “Cti logistics limited”, filings range from 2020-08-27 to 2021-08-27. The filers whose documents mention it most often are FIDELITY PURITAN TRUST (CIK 0000081205) (2 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 23 entities whose registered name contains the word “cti”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “cti” 23, “logistics” 487. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “cti” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Damora therapeutics, inc. bullish and bearish analyst opinions

For “Damora therapeutics, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Damora Therapeutics, Inc., which trades as DMRA and files under Central Index Key 1800315. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Galecto, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-28, across 352 filings on record. This is reference material, not trading advice.

Financial trend for Damora Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$61.62 million (2022-12-31) to -$209.84 million (2025-12-31), a change of -240.5%; total assets went from $73.19 million (2022-12-31) to $260.53 million (2025-12-31), a change of +256.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1800315, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Damora Therapeutics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Damora Therapeutics, Inc. (CIK 1800315) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-03-10, and the most recent 10-K annual report was filed 2026-03-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 40 8-K or 6-K reports in Damora Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-04-20 to 2026-07-20, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 352 recent EDGAR filings, Damora Therapeutics, Inc. most often filed 4 (106), 8-K (40), 144 (38), 3 (29). A selection from 2026-08-10 to 2026-09-28:

The full record for CIK 1800315 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2020-01-16. Insider trades for Damora Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Dana eaton mobility

Two vehicle-components names, Dana and Eaton, searched under the word “mobility”. Every name is matched to its own EDGAR record (checked Oct 25, 2026), since none of these companies reports on behalf of another.

Eaton Corp plc (ETN; misc industrial & commercial machinery & equipment) — EDGAR lists the 8-K of 2026-07-31 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2026-06-11 covering 7.01 (regulation fd disclosure), 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2015-12-31: annual sales of $0 (10-K, 2017-02-22).

DANA Inc (DAN; motor vehicle parts & accessories, incorporated in DE) — recent current reports: the 8-K of 2026-08-06 covering 2.02 (results of operations and financial condition), 7.01 (regulation fd disclosure), 9.01 (financial statements and exhibits); the 8-K of 2026-07-10 covering 1.01 (entry into a material definitive agreement), 2.03 (creation of a direct financial obligation), 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2025-12-31: revenue of $7.50 billion, net income (loss) $85.00 million (10-K, 2026-02-27).

Frequency of Item 2.02 (results of operations and financial condition — the item that accompanies an earnings release) in recent filings — ETN 40 (latest 2026-07-31), DAN 36 (latest 2026-08-06).

Eaton reports its vehicle and eMobility businesses as separate segments alongside its much larger electrical operations, and Dana is a drivetrain and electrification supplier, so the overlap between them lies in vehicle components. Segment results in each 10-K show how much revenue each company draws from vehicle markets compared with the rest of its business.

Dariohealth corp. bullish and bearish analyst opinions

For “Dariohealth corp. bullish and bearish analyst opinions”, the matching SEC registrant is DarioHealth Corp., which trades as DRIO and files under Central Index Key 1533998. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with DE as its state or country of incorporation; its earlier registered name was LabStyle Innovations Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-28 (this view begins at filings dated on or before 2026-08-21), across 903 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-19 by DarioHealth Corp. (CIK 1533998) (passage 2, continuing from the earlier excerpt) — source document:

We, and our acquired companies, first commercialized our digital behavioral health products in the direct-to-consumer (“D2C”) marketplace, and we continue to use the D2C marketplace as a sandbox and laboratory to innovation. These consumers pay for these digital health products out of their own pockets and are therefore the most value driven among all healthcare consumers. These consumers demanded that we deliver highly engaging user experiences that deliver strong clinical health outcomes for which consumers will pay. The bottom line is that if users are not engaged in digital solutions over a long period of time, they cannot change their behavior and they cannot get healthier – we first deliver engagement followed by sustained behavior change that then leads to measurable health outcomes and improvement.

Financial trend for DarioHealth Corp. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from -$10.47 million (2025-09-30) to -$7.92 million (2026-06-30), a change of +24.3%; total assets went from $117.73 million (2025-09-30) to $96.59 million (2026-06-30), a change of -18.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1533998, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures DarioHealth Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on DarioHealth Corp. (CIK 1533998) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2023-07-24, and the most recent 10-K annual report was filed 2026-03-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 145 8-K or 6-K reports in DarioHealth Corp.’s recent EDGAR index, the 4 listed here run from 2026-01-29 to 2026-04-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1533998 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2011-11-01. One example from this record is the 4 filed 2026-09-28 (document). Insider trades for DarioHealth Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Datasea intelligent technology ltd. bullish and bearish analyst opinions

For “Datasea intelligent technology ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Datasea Intelligent Technology Ltd., which trades as DTSS and files under Central Index Key 2110423. EDGAR puts it in the “Services-Prepackaged Software” industry code with Virgin Islands, British as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 20-F filed 2026-10-02, across 17 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-10-02 by Datasea Intelligent Technology Ltd. (CIK 2110423) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 49 A. Operating Results 49 B. Liquidity and Capital Resources 60 C. Research and Development, Patents and Licenses 65 D. Trend Information 66 E. Critical Accounting Estimates 67 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 68 A. Directors and Senior Management 68 B. Compensation 70 C. Board Practices 73 D. Employees 75 E. Share Ownership 76 F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 76 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 77 A. Major Shareholders 77 B. Related Party Transactions 77 C. Interests of Experts and Counsel 77 ITEM 8. FINANCIAL INFORMATION 78 A. Consolidated Statements and Other Financial Information 78 B. Significant Changes 79 ITEM 9.

Financial trend for Datasea Intelligent Technology Ltd. from annual reports, periods 2024-06-30 to 2026-06-30: revenue went from $23.98 million (2024-06-30) to $40.70 million (2026-06-30), a change of +69.7%; net income (loss) went from -$11.38 million (2024-06-30) to -$2.19 million (2026-06-30), a change of +80.8%; total assets went from $6.74 million (2025-06-30) to $14.77 million (2026-06-30), a change of +119.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2110423, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Datasea Intelligent Technology Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Datasea Intelligent Technology Ltd. (CIK 2110423) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-10-02. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 5 8-K or 6-K reports in Datasea Intelligent Technology Ltd.’s recent EDGAR index, the 4 listed here run from 2026-06-12 to 2026-09-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2110423 is on the EDGAR company page; the latest 20-F there is dated 2026-10-02 and the oldest filing in the recent index dates from 2026-02-13. Insider trades for Datasea Intelligent Technology Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ddi trading reddit

For “Ddi trading reddit”, the matching SEC registrant is DoubleDown Interactive Co., Ltd., which trades as DDI and files under Central Index Key 1799567. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with Korea, Republic of as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-11, across 200 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-03-31 by DoubleDown Interactive Co., Ltd. (CIK 1799567) — source document:

In 2016, DUG acquired a controlling stake in our Company and, in 2017, DUG acquired the remaining stake in our Company, making us a wholly-owned subsidiary of DUG. Later in 2017, DUG also acquired DDI-US through our Company, believing that our strengths could be highly complementary to DDI-US for creating more powerful social casino gaming content. We changed our name to DoubleDown Interactive Co., Ltd. in December 2019. In February 2020, we acquired Korea-based Double8 Games from DUG. In October 2023, we acquired SuprNation, a European iGaming operator, and in July 2025, we acquired WHOW Games, a social casino developer based in Germany. SuprNation and WHOW Games are direct, wholly-owned subsidiaries of DDI-US. See “—B. Business Overview” below and Note 30: Acquisition to our audited consolidated financial statements included elsewhere in this annual report.

Financial trend for DoubleDown Interactive Co., Ltd. from annual reports, periods 2020-12-31 to 2023-12-31: revenue went from $358.34 million (2020-12-31) to $308.86 million (2023-12-31), a change of -13.8%; net income (loss) went from $53.62 million (2020-12-31) to $100.89 million (2023-12-31), a change of +88.1%; total assets went from $806.83 million (2020-12-31) to $803.34 million (2023-12-31), a change of -0.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1799567, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures DoubleDown Interactive Co., Ltd. did not tag for that period.

Reddit threads about DoubleDown Interactive Co., Ltd., CIK 1799567, are user opinions, not disclosures. Claims made there can be checked against the filer record: 200 filings sit in its recent EDGAR index, the newest a 6-K dated 2026-09-11, and 2 insider Form 4 reports are among them. The SEC’s Investor.gov site warns that social-media hype around small listed companies is a common feature of pump-and-dump schemes.

Current reports. Of the 100 8-K or 6-K reports in DoubleDown Interactive Co., Ltd.’s recent EDGAR index, the 4 listed here run from 2026-06-01 to 2026-09-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1799567 is on the EDGAR company page; the latest 20-F there is dated 2026-03-31 and the oldest filing in the recent index dates from 2020-01-22. Insider trades for DoubleDown Interactive Co., Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Defsec technologies inc. bullish and bearish analyst opinions

For “Defsec technologies inc. bullish and bearish analyst opinions”, the matching SEC registrant is DEFSEC Technologies Inc., which trades as DFSC, DFSCW and files under Central Index Key 1889823. EDGAR puts it in the “Services-Prepackaged Software” industry code with British Columbia, Canada as its state or country of incorporation; its earlier registered name was KWESST Micro Systems Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-20, across 257 filings on record. This is reference material, not trading advice.

Financial trend for DEFSEC Technologies Inc. from annual reports, periods 2021-09-30 to 2024-09-30: revenue went from 1,275,804 CAD (2021-09-30) to 1,504,328 CAD (2024-09-30), a change of +17.9%; net income (loss) went from -9,315,372 CAD (2021-09-30) to -7,437,759 CAD (2024-09-30), a change of +20.2%; total assets went from 8,717,846 CAD (2021-09-30) to 5,617,148 CAD (2024-09-30), a change of -35.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1889823, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures DEFSEC Technologies Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on DEFSEC Technologies Inc. (CIK 1889823) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2025-12-29. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 121 8-K or 6-K reports in DEFSEC Technologies Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-18 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 257 recent EDGAR filings, DEFSEC Technologies Inc. most often filed 6-K (121), CORRESP (35), UPLOAD (14), EFFECT (11). A selection from 2026-08-03 to 2026-09-09:

The full record for CIK 1889823 is on the EDGAR company page; the latest 20-F there is dated 2025-12-29 and the oldest filing in the recent index dates from 2022-07-05. Insider trades for DEFSEC Technologies Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Deswell industries, inc. bullish and bearish analyst opinions

For “Deswell industries, inc. bullish and bearish analyst opinions”, the matching SEC registrant is DESWELL INDUSTRIES INC, which trades as DSWL and files under Central Index Key 946936. EDGAR puts it in the “Plastics Products, NEC” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-18, across 339 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-07-30 by DESWELL INDUSTRIES INC (CIK 946936) — source document:

Deswell Industries, Inc. was founded in 1987 in Hong Kong and moved its manufacturing operations to China in 1990 to take advantage of lower overhead cost, competitive labor rate and tax concessions available in Shenzhen, China as compared with Hong Kong. We were incorporated in December 1993 as a limited liability International Business Company under the British Virgin Islands International Business Companies Act, 1984 (the “IBC Act”). Effective on January 1, 2007, the BVI repealed the IBC Act, and simultaneously with such repeal, we were automatically re-registered under the BVI’s corporate law replacing the IBC Act, the BVI Business Companies Act, 2004 (the “BVI BC Act”). The Company’s registered agent in the BVI is Harneys Corporate Services Limited, P.O. Box 71, Craigmuir Chambers, Road Town, Tortola, British Virgin Islands.

Financial trend for DESWELL INDUSTRIES INC from annual reports, periods 2023-03-31 to 2026-03-31: revenue went from $77.34 million (2023-03-31) to $61.33 million (2026-03-31), a change of -20.7%; net income (loss) went from $2.06 million (2023-03-31) to $10.63 million (2026-03-31), a change of +416.1%; total assets went from $110.38 million (2023-03-31) to $129.96 million (2026-03-31), a change of +17.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 946936, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures DESWELL INDUSTRIES INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on DESWELL INDUSTRIES INC (CIK 946936) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-07-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 177 8-K or 6-K reports in DESWELL INDUSTRIES INC’s recent EDGAR index, the 4 listed here run from 2026-02-03 to 2026-09-18, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 946936 is on the EDGAR company page; the latest 20-F there is dated 2026-07-30 and the oldest filing in the recent index dates from 2000-11-01. Insider trades for DESWELL INDUSTRIES INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Douglas elliman inc. bullish and bearish analyst opinions

For “Douglas elliman inc. bullish and bearish analyst opinions”, the matching SEC registrant is Douglas Elliman Inc., which trades as DOUG and files under Central Index Key 1878897. EDGAR puts it in the “Real Estate Agents & Managers (For Others)” industry code with DE as its state or country of incorporation; its earlier registered name was Douglas Elliman Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-04, across 301 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-16 by Douglas Elliman Inc. (CIK 1878897) — source document:

Douglas Elliman Inc. is a holding company that, through its subsidiaries, is engaged in the real estate services business. Douglas Elliman owns Douglas Elliman Realty, LLC, one of the largest residential brokerage companies in the New York metropolitan area, which includes New York City, Long Island, the Hamptons, Westchester, Connecticut and New Jersey, and also conducts operations in Florida, California, Texas, Colorado, Nevada, Massachusetts, Maryland, Virginia, and Washington D.C. We also offer, including through our subsidiaries and ventures, development marketing services and ancillary services, such as mortgage, title and escrow services. Douglas Elliman Inc. is a Delaware corporation incorporated in 2021 in connection with the separation of Douglas Elliman from Vector Group Ltd., as an independent, publicly traded company, listed on the New York Stock Exchange.

Financial trend for Douglas Elliman Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.15 billion (2022-12-31) to $955.58 million (2023-12-31), a change of -17.1%; net income (loss) went from -$5.62 million (2022-12-31) to $15.22 million (2025-12-31), a change of +370.7%; total assets went from $550.40 million (2022-12-31) to $444.41 million (2025-12-31), a change of -19.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1878897, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Douglas Elliman Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Douglas Elliman Inc. (CIK 1878897) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-07, and the most recent 10-K annual report was filed 2026-03-16. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 51 8-K or 6-K reports in Douglas Elliman Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-18 to 2026-09-04, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1878897 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2021-08-24. Insider trades for Douglas Elliman Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Dv biomed co., ltd. bullish and bearish analyst opinions

“Co., Ltd.” is the English rendering used by limited companies across East Asia. The name “Dv biomed co., ltd.” therefore points to a company organised in China, Taiwan, Korea or Japan, and its official disclosures are on the home-exchange disclosure system (SSE/SZSE in mainland China, MOPS in Taiwan, DART in Korea, EDINET in Japan) (mops.twse.com.tw), not on EDGAR.

No SEC filer could be matched to “Dv biomed co., ltd. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Dv biomed co., ltd.” appears in 4 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “biomed” (search terms considered: biomed).

A broader EDGAR full-text search for the shorter phrase “Dv biomed co.” finds 4 filing documents; among the top 4, the filers mentioning it most are SEI INSTITUTIONAL INVESTMENTS TRUST (CIK 0000939934) (4). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 4 most relevant full-text hits returned for “Dv biomed co., ltd.”, filings range from 2023-05-01 to 2024-02-21. The filers whose documents mention it most often are SEI INSTITUTIONAL INVESTMENTS TRUST (CIK 0000939934) (4 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 65 entities whose registered name contains the word “biomed”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “biomed” 65. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “biomed” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Ellomay capital ltd. bullish and bearish analyst opinions

For “Ellomay capital ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Ellomay Capital Ltd., which trades as ELLO and files under Central Index Key 946394. EDGAR puts it in the “Electric Services” industry code with Israel as its state or country of incorporation; its earlier registered name was NUR MACROPRINTERS LTD. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K/A filed 2026-10-15, across 667 filings on record. This is reference material, not trading advice.

Financial trend for Ellomay Capital Ltd. from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from 44,705,000 EUR (2021-12-31) to 40,467,000 EUR (2024-12-31), a change of -9.5%; net income (loss) went from -19,640,000 EUR (2021-12-31) to -9,006,000 EUR (2024-12-31), a change of +54.1%; total assets went from 551,979,000 EUR (2021-12-31) to 677,257,000 EUR (2024-12-31), a change of +22.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 946394, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Ellomay Capital Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Ellomay Capital Ltd. (CIK 946394) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-05-01. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 481 8-K or 6-K reports in Ellomay Capital Ltd.’s recent EDGAR index, the 4 listed here run from 2026-08-31 to 2026-10-14, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 667 recent EDGAR filings, Ellomay Capital Ltd. most often filed 6-K (481), 20-F (29), SC 13G/A (28), SC 13D/A (20). A selection from 2026-08-04 to 2026-10-15:

The full record for CIK 946394 is on the EDGAR company page; the latest 20-F there is dated 2026-05-01 and the oldest filing in the recent index dates from 1998-06-30. Insider trades for Ellomay Capital Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Eloxx pharmaceuticals, inc. bullish and bearish analyst opinions

For “Eloxx pharmaceuticals, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Eloxx Pharmaceuticals, Inc., which trades as ELOX and files under Central Index Key 1035354. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Sevion Therapeutics, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 424B3 filed 2026-10-22 (this view begins at filings dated on or before 2026-07-27), across 1000 filings on record. This is reference material, not trading advice.

Financial trend for Eloxx Pharmaceuticals, Inc. from quarterly and annual reports (three-month periods), periods 2025-06-30 to 2026-06-30: net income (loss) went from -$1.89 million (2025-06-30) to -$4.50 million (2026-06-30), a change of -138.1%; total assets went from $8.50 million (2026-03-31) to $63.39 million (2026-06-30), a change of +645.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1035354, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Eloxx Pharmaceuticals, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Eloxx Pharmaceuticals, Inc. (CIK 1035354) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-03-17. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 246 8-K or 6-K reports in Eloxx Pharmaceuticals, Inc.’s recent EDGAR index, the 4 listed here run from 2024-03-29 to 2025-08-12, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1000 recent EDGAR filings, Eloxx Pharmaceuticals, Inc. most often filed 4 (394), 8-K (246), 10-Q (47), 3 (42). A selection from 2026-06-17 to 2026-08-14:

The full record for CIK 1035354 is on the EDGAR company page; the latest 10-K there is dated 2026-03-17 and the oldest filing in the recent index dates from 2008-12-23. One example from this record is the EFFECT filed 2026-09-18 (document). Insider trades for Eloxx Pharmaceuticals, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Emmis corporation bullish and bearish analyst opinions

For “Emmis corporation bullish and bearish analyst opinions”, the matching SEC registrant is EMMIS CORP, which trades as none listed and files under Central Index Key 783005. EDGAR puts it in the “Radio Broadcasting Stations” industry code with IN as its state or country of incorporation; its earlier registered name was EMMIS COMMUNICATIONS CORP. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2025-01-06, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2020-05-14 by EMMIS CORP (CIK 783005) — source document:

We are a diversified media company, formed in 1980, principally focused on radio broadcasting. Emmis owns 4 FM and 2 AM radio stations in New York and Indianapolis. One of the FM radio stations that Emmis currently owns in New York is operated pursuant to a Local Marketing Agreement (“LMA”) whereby a third party provides the programming for the station and sells all advertising within that programming. In addition to our radio properties, we also publish Indianapolis Monthly and operate a dynamic pricing business (“Digonex”). In March 2020, we acquired the sound masking business of Lencore Acoustics Corporation for $75.1 million as part of our operating strategy to diversify into businesses that display better growth characteristics than the radio and magazine businesses that have historically comprised substantially all of our operating results.

Financial trend for EMMIS CORP from annual reports, periods 2017-02-28 to 2020-02-29: revenue went from $214.57 million (2017-02-28) to $114.13 million (2019-02-28), a change of -46.8%; net income (loss) went from $13.12 million (2017-02-28) to $50.48 million (2020-02-29), a change of +284.8%; total assets went from $289.34 million (2017-02-28) to $221.99 million (2020-02-29), a change of -23.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 783005, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures EMMIS CORP did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on EMMIS CORP (CIK 783005) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2019-07-11, and the most recent 10-K annual report was filed 2020-05-14. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 133 8-K or 6-K reports in EMMIS CORP’s recent EDGAR index, the 4 listed here run from 2020-02-10 to 2020-04-24, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 783005 is on the EDGAR company page; the latest 10-K/A there is dated 2020-06-24 and the oldest filing in the recent index dates from 2010-01-04. Insider trades for EMMIS CORP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Enovix x

For “Enovix x”, the matching SEC registrant is Enovix Corp, which trades as ENVX and files under Central Index Key 1828318. EDGAR puts it in the “Miscellaneous Electrical Machinery, Equipment & Supplies” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was Rodgers Silicon Valley Acquisition Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 818 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-25 by Enovix Corp (CIK 1828318) — source document:

Enovix Corporation (the “Company,” “we,” “us,” “our” and “Enovix”) is a global high-performance battery company focused on designing, developing, manufacturing, and commercializing advanced Lithium-ion, or Li-ion, batteries, including proprietary silicon-anode architectures, for smartphones, smart eyewear, defense, industrial and emerging edge-AI applications. Our proprietary silicon-anode battery architecture enables higher energy density and performance relative to conventional battery cells, particularly in space-constrained devices. Our battery’s mechanical design, or “architecture,” allows us to use high performance chemistries while maintaining safety and reliability, supporting commercialization opportunities across various consumer and industrial markets. Battery performance has become a critical constraint for modern electronic devices as they continue to incorporate slimmer designs with greater functionality, longer runtime, and higher power needs.

Financial trend for Enovix Corp from annual reports, periods 2023-01-01 to 2025-12-28: revenue went from $6.20 million (2023-01-01) to $31.82 million (2025-12-28), a change of +413.1%; net income (loss) went from -$51.62 million (2023-01-01) to -$156.74 million (2025-12-28), a change of -203.6%; total assets went from $440.59 million (2023-01-01) to $878.98 million (2025-12-28), a change of +99.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1828318, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Enovix Corp did not tag for that period.

Enovix Corp has 818 filings in its recent EDGAR index, including 6 annual reports and 17 quarterly reports; its newest filing is a 8-K from 2026-10-22.

Current reports. Of the 80 8-K or 6-K reports in Enovix Corp’s recent EDGAR index, the 4 listed here run from 2026-08-12 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1828318 is on the EDGAR company page; the latest 10-K/A there is dated 2026-02-26 and the oldest filing in the recent index dates from 2020-10-14. Insider trades for Enovix Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Essex bio-technology limited bullish and bearish analyst opinions

Read from its name, “Essex bio-technology limited” is a a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada) entity — “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. Its accounts and exchange notices are published through that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Essex bio-technology limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Essex bio-technology limited” appears in 62 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “essex” (search terms considered: essex, bio-technology).

In the 62 most relevant full-text hits returned for “Essex bio-technology limited”, filings range from 2016-08-30 to 2026-08-26. The filers whose documents mention it most often are John Hancock Funds II (CIK 0001331971) (18 hits); AC Immune SA (ACIU) (CIK 0001651625) (12 hits); Humacyte, Inc. (HUMA, HUMAW) (CIK 0001818382) (9 hits); AMERICAN CENTURY ETF TRUST (CIK 0001710607) (5 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 120 entities whose registered name contains the word “essex”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “essex” 120, “bio-technology” 8. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “essex” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Everbright grand china assets limited bullish and bearish analyst opinions

“Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. The name “Everbright grand china assets limited” therefore points to a company organised in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), and its official disclosures are on that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk), not on EDGAR.

No SEC filer could be matched to “Everbright grand china assets limited bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Everbright grand china assets limited”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “everbright” (search terms considered: everbright, grand, china, assets).

Even the shorter phrase “Everbright grand china” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (everbright, grand, china, assets) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 14 entities whose registered name contains the word “everbright”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “everbright” 14, “grand” 497, “china” 456, “assets” 480. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “everbright”: CHINA EVERBRIGHT BANK CO LIMITED/ADR (CIK 1611482), CHINA EVERBRIGHT HOLDINGS CO LTD (CIK 1206703), CHINA EVERBRIGHT INTERNATIONAL LIMITED/ADR (CIK 1601994); containing “grand”: 07 GRAND REWARD/ROSE CITY, LLC (CIK 1462597), 08 GRAND SLAM/FEMININE, LLC (CIK 1508945), 1100 GRAND CHICAGO INVESTORS LLC (CIK 2045861); containing “china”: AACP CHINA DEBT INVESTORS LP (CIK 1426324), AACP CHINA GROWTH INVESTORS II, L.P. (CIK 1478696), AACP CHINA GROWTH INVESTORS III, L.P. (CIK 1478722); containing “assets”: 114 ASSETS INC. (CIK 1952761), 2013 NATURAL RESOURCES SERIES, A SERIES OF GRESHAM REAL ASSETS STRATEGIES, L.P. (CIK 1570084), 2013 SEGREGATED PORTFOLIO, A SEGREGATED PORTFOLIO OF SCIENS REAL ASSETS OFFSHORE FUND SPC (CIK 1691075). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: analyst views on “everbright” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Exzeo group, inc. bullish and bearish analyst opinions

For “Exzeo group, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Exzeo Group, Inc., which trades as XZO and files under Central Index Key 1873951. EDGAR puts it in the “Services-Prepackaged Software” industry code with FL as its state or country of incorporation; its earlier registered name was TypTap Insurance Group, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-08-14, across 108 filings on record. This is reference material, not trading advice.

Financial trend for Exzeo Group, Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $88.33 million (2023-12-31) to $216.98 million (2025-12-31), a change of +145.6%; net income (loss) went from $21.46 million (2023-12-31) to $82.75 million (2025-12-31), a change of +285.6%; total assets went from $89.44 million (2024-12-31) to $347.73 million (2025-12-31), a change of +288.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1873951, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Exzeo Group, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Exzeo Group, Inc. (CIK 1873951) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-06, and the most recent 10-K annual report was filed 2026-02-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 11 8-K or 6-K reports in Exzeo Group, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-26 to 2026-08-14, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 108 recent EDGAR filings, Exzeo Group, Inc. most often filed 4 (59), 8-K (11), 3 (9), 10-Q (3). A selection from 2026-05-22 to 2026-08-07:

The full record for CIK 1873951 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2021-08-03. Insider trades for Exzeo Group, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ezgo technologies ltd. bullish and bearish analyst opinions

For “Ezgo technologies ltd. bullish and bearish analyst opinions”, the matching SEC registrant is EZGO Technologies Ltd., which trades as EZGO and files under Central Index Key 1806904. EDGAR puts it in the “Motorcycles, Bicycles & Parts” industry code with Virgin Islands, British as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-08-20, across 156 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2025-12-30 by EZGO Technologies Ltd. (CIK 1806904) — source document:

EZGO was incorporated in BVI on January 24, 2019. EZGO’s wholly-owned subsidiary, EZGO HK, was incorporated in Hong Kong on February 13, 2019. EZGO HK holds all of the capital stock of Changzhou EZGO, which was incorporated in China on June 12, 2019, and Changzhou Langyi, which was incorporated in China on August 6, 2021. EZGO is a holding company with no material operations of its own, and substantially all of its operations and assets are located in China. EZGO conducts its business in China through its subsidiaries. Beginning in November 2019, EZGO conducted a portion of its business in China through VIE and the VIE’s subsidiaries. During this period, Changzhou EZGO controlled the VIE through a series of contractual arrangements and EZGO was considered the primary beneficiary of the VIE for accounting purposes.

Financial trend for EZGO Technologies Ltd. from annual reports, periods 2021-09-30 to 2024-09-30: revenue went from $23.42 million (2021-09-30) to $21.13 million (2024-09-30), a change of -9.8%; net income (loss) went from -$3.41 million (2021-09-30) to -$7.28 million (2024-09-30), a change of -113.4%; total assets went from $42.01 million (2021-09-30) to $85.36 million (2024-09-30), a change of +103.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1806904, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures EZGO Technologies Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on EZGO Technologies Ltd. (CIK 1806904) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2025-12-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 57 8-K or 6-K reports in EZGO Technologies Ltd.’s recent EDGAR index, the 4 listed here run from 2026-05-15 to 2026-08-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1806904 is on the EDGAR company page; the latest 20-F there is dated 2025-12-30 and the oldest filing in the recent index dates from 2020-04-17. Insider trades for EZGO Technologies Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fibrobiologics, inc. common stock bullish and bearish analyst opinions

For “Fibrobiologics, inc. common stock bullish and bearish analyst opinions”, the matching SEC registrant is FibroBiologics, Inc., which trades as FBLG and files under Central Index Key 1958777. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was FibroBiologics Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a EFFECT filed 2026-10-19, across 242 filings on record. This is reference material, not trading advice.

Financial trend for FibroBiologics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$5.12 million (2022-12-31) to -$18.65 million (2025-12-31), a change of -264.1%; total assets went from $4.82 million (2022-12-31) to $9.62 million (2025-12-31), a change of +99.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1958777, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures FibroBiologics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on FibroBiologics, Inc. (CIK 1958777) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-02-24. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 46 8-K or 6-K reports in FibroBiologics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-24 to 2026-10-08, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 242 recent EDGAR filings, FibroBiologics, Inc. most often filed 8-K (46), 4 (37), CORRESP (14), S-1/A (13). A selection from 2026-10-13 to 2026-10-19:

The full record for CIK 1958777 is on the EDGAR company page; the latest 10-K/A there is dated 2026-03-13 and the oldest filing in the recent index dates from 2023-01-31. Insider trades for FibroBiologics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Filana therapeutics, inc. bullish and bearish analyst opinions

For “Filana therapeutics, inc. bullish and bearish analyst opinions”, the matching SEC registrant is FILANA THERAPEUTICS, INC., which trades as FLNA and files under Central Index Key 1069530. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was CASSAVA SCIENCES INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-20, across 1000 filings on record. This is reference material, not trading advice.

Financial trend for FILANA THERAPEUTICS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$76.25 million (2022-12-31) to -$90.97 million (2025-12-31), a change of -19.3%; total assets went from $234.83 million (2022-12-31) to $118.36 million (2025-12-31), a change of -49.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1069530, tags Assets, NetIncomeLoss, SalesRevenueNet; 4 periods shown, dashes mark figures FILANA THERAPEUTICS, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on FILANA THERAPEUTICS, INC. (CIK 1069530) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-29, and the most recent 10-K annual report was filed 2026-03-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 224 8-K or 6-K reports in FILANA THERAPEUTICS, INC.’s recent EDGAR index, the 4 listed here run from 2026-07-29 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1000 recent EDGAR filings, FILANA THERAPEUTICS, INC. most often filed 4 (447), 8-K (224), SC 13G/A (89), 10-Q (59). A selection from 2026-04-28 to 2026-10-01:

The full record for CIK 1069530 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2006-11-09. Insider trades for FILANA THERAPEUTICS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Flanigan's enterprises, inc. bullish and bearish analyst opinions

For “Flanigan's enterprises, inc. bullish and bearish analyst opinions”, the matching SEC registrant is FLANIGANS ENTERPRISES INC, which trades as BDL and files under Central Index Key 12040. EDGAR puts it in the “Retail-Eating Places” industry code with FL as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-08-11, across 313 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2025-12-19 by FLANIGANS ENTERPRISES INC (CIK 12040) — source document:

As of September 27, 2025, Flanigan’s Enterprises, Inc., a Florida corporation, together with its subsidiaries (“we”, “our”, “ours” and “us” as the context requires), (i) operates 32 units, consisting of restaurants, package liquor stores, combination restaurant/package liquor stores and a sports bar that we either own or have operational control over and partial ownership in; and (ii) franchises an additional 5 units, consisting of 2 restaurants (one of which we operate) and 3 combination restaurant/package liquor stores. The table below provides information concerning the type (i.e. restaurant, sports bar, package liquor store or combination restaurant/package liquor store) and ownership of the units (i.e. whether (i) we own 100% of the unit; (ii) the unit is owned by a limited partnership of which we are the sole general partner and/or have invested in; or (iii) the unit is franchised by us), as of September 27, 2025 and as compared to September 28, 2024.

Financial trend for FLANIGANS ENTERPRISES INC from annual reports, periods 2022-10-01 to 2025-09-27: revenue went from $158.13 million (2022-10-01) to $205.25 million (2025-09-27), a change of +29.8%; net income (loss) went from $6.31 million (2022-10-01) to $5.03 million (2025-09-27), a change of -20.3%; total assets went from $147.49 million (2022-10-01) to $140.62 million (2025-09-27), a change of -4.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 12040, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures FLANIGANS ENTERPRISES INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on FLANIGANS ENTERPRISES INC (CIK 12040) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2025-12-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 26 8-K or 6-K reports in FLANIGANS ENTERPRISES INC’s recent EDGAR index, the 4 listed here run from 2025-05-13 to 2026-03-02, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 12040 is on the EDGAR company page; the latest 10-K there is dated 2025-12-19 and the oldest filing in the recent index dates from 1995-05-23. Insider trades for FLANIGANS ENTERPRISES INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fusemachines inc. bullish and bearish analyst opinions

For “Fusemachines inc. bullish and bearish analyst opinions”, the matching SEC registrant is Fusemachines Inc., which trades as FUSE, FUSEW and files under Central Index Key 2033383. EDGAR puts it in the “Services-Computer Integrated Systems Design” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was CSLM Holdings Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-23, across 96 filings on record. This is reference material, not trading advice.

Financial trend for Fusemachines Inc. from annual reports, periods 2024-12-31 to 2025-12-31: revenue went from $8.81 million (2024-12-31) to $7.71 million (2025-12-31), a change of -12.5%; net income (loss) went from -$15.38 million (2024-12-31) to -$928,000 (2025-12-31), a change of +94.0%; total assets went from $5.55 million (2024-12-31) to $7.54 million (2025-12-31), a change of +35.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2033383, tags Assets, NetIncomeLoss, Revenues; 2 periods shown, dashes mark figures Fusemachines Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Fusemachines Inc. (CIK 2033383) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 22 8-K or 6-K reports in Fusemachines Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-15 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 96 recent EDGAR filings, Fusemachines Inc. most often filed 8-K (22), 4 (12), 3 (11), CORRESP (8). A selection from 2026-08-07 to 2026-10-13:

The full record for CIK 2033383 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2024-11-27. Insider trades for Fusemachines Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Futurewave acquisition corp. bullish and bearish analyst opinions

For “Futurewave acquisition corp. bullish and bearish analyst opinions”, the matching SEC registrant is Futurewave Acquisition Corp, which trades as FWAC, FWACR, FWACU, FWACW and files under Central Index Key 2116105. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 425 filed 2026-09-29 (this view begins at filings dated on or before 2026-07-02), across 24 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on Futurewave Acquisition Corp (CIK 2116105) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Other filings. Across its 24 recent EDGAR filings, Futurewave Acquisition Corp most often filed 3 (5), 8-K (4), S-1/A (3), SCHEDULE 13G (2). A selection from 2026-07-02 to 2026-07-02:

The full record for CIK 2116105 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-04-15. One example from this record is the 10-Q filed 2026-08-13 (document). Insider trades for Futurewave Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fvcbankcorp, inc. bullish and bearish analyst opinions

For “Fvcbankcorp, inc. bullish and bearish analyst opinions”, the matching SEC registrant is FVCBankcorp, Inc., which trades as FVCB and files under Central Index Key 1675644. EDGAR puts it in the “State Commercial Banks” industry code with VA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 590 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-16 by FVCBankcorp, Inc. (CIK 1675644) — source document:

We operate primarily through our sole subsidiary, FVCbank (the "Bank"), a community oriented, locally-owned and managed commercial bank organized under the laws of the Commonwealth of Virginia. We serve the banking needs of commercial businesses, nonprofit organizations, professional service entities, and their respective owners and employees located in the greater Washington, D.C. and Baltimore metropolitan areas. The Company was established as the holding company for the Bank in 2015. Since the Bank began operations in November 2007, it has grown largely organically, through de novo branch expansion, banker and customer acquisition, and two whole-bank acquisitions. In 2012, we completed the acquisition of 1st Commonwealth Bank of Virginia ("1 st Commonwealth"), a $58.9 million asset savings and loan association in Arlington, Virginia.

Financial trend for FVCBankcorp, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.43 million (2022-12-31) to $1.78 million (2025-12-31), a change of +24.4%; net income (loss) went from $24.98 million (2022-12-31) to $22.06 million (2025-12-31), a change of -11.7%; total assets went from $2.34 billion (2022-12-31) to $2.29 billion (2025-12-31), a change of -2.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1675644, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures FVCBankcorp, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on FVCBankcorp, Inc. (CIK 1675644) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-10-22, and the most recent 10-K annual report was filed 2026-03-16. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 85 8-K or 6-K reports in FVCBankcorp, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-05 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1675644 is on the EDGAR company page; the latest 10-K/A there is dated 2026-03-25 and the oldest filing in the recent index dates from 2016-06-28. Insider trades for FVCBankcorp, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Galaxyedge acquisition corporation bullish and bearish analyst opinions

For “Galaxyedge acquisition corporation bullish and bearish analyst opinions”, the matching SEC registrant is GalaxyEdge Acquisition Corp, which trades as GLED, GLED-RI, GLED-UN and files under Central Index Key 2091484. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-08-14, across 38 filings on record. This is reference material, not trading advice.

Financial trend for GalaxyEdge Acquisition Corp from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from $157,011 (2026-03-31) to $584,910 (2026-06-30), a change of +272.5%; total assets went from $116.66 million (2026-03-31) to $117.21 million (2026-06-30), a change of +0.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2091484, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures GalaxyEdge Acquisition Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on GalaxyEdge Acquisition Corp (CIK 2091484) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for GalaxyEdge Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 7 such filings (424B4, 425, S-1, S-1/A) appear in its recent index, the newest dated 2026-05-01.

Current reports. Of the 6 8-K or 6-K reports in GalaxyEdge Acquisition Corp’s recent EDGAR index, the 4 listed here run from 2026-03-11 to 2026-05-01, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 38 recent EDGAR filings, GalaxyEdge Acquisition Corp most often filed SCHEDULE 13G (7), 8-K (6), 3 (5), SCHEDULE 13G/A (3). A selection from 2026-07-16 to 2026-08-14:

The full record for CIK 2091484 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-10-15. Insider trades for GalaxyEdge Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Gcm grosvenor inc. bullish and bearish analyst opinions

For “Gcm grosvenor inc. bullish and bearish analyst opinions”, the matching SEC registrant is GCM Grosvenor Inc., which trades as GCMG and files under Central Index Key 1819796. EDGAR puts it in the “Investment Advice” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-02, across 522 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-19 by GCM Grosvenor Inc. (CIK 1819796) — source document:

Our clients include large, sophisticated, global institutional investors and a growing individual investor client base. In both cases, our clients rely on our investment expertise and differentiated, diversified investment sourcing to navigate the alternatives market. As one of the pioneers of customized separate account solutions, we are equipped to provide investment services to clients with a wide variety of needs, internal resources and investment objectives, and our client relationships are deep and frequently span decades. As of December 31, 2025, we had 553 employees, including 185 investment professionals, operating in nine offices throughout the United States and in Frankfurt, Hong Kong, London, Seoul, Sydney, Tokyo and Toronto. For the years ended December 31, 2025 and 2024, our total management fees were $426 million and $402 million, respectively , our total operating revenues were $558 million and $514 million, respectively, our net income was $45 million and $19 million, respectively, our fee related earnings were $185 million and $166 million, respectively, and our adjusted net income was $166 million and $141 million, respectively.

Financial trend for GCM Grosvenor Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $446.53 million (2022-12-31) to $557.57 million (2025-12-31), a change of +24.9%; net income (loss) went from $19.82 million (2022-12-31) to $45.37 million (2025-12-31), a change of +128.9%; total assets went from $488.93 million (2022-12-31) to $813.76 million (2025-12-31), a change of +66.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1819796, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures GCM Grosvenor Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on GCM Grosvenor Inc. (CIK 1819796) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-10, and the most recent 10-K annual report was filed 2026-02-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 45 8-K or 6-K reports in GCM Grosvenor Inc.’s recent EDGAR index, the 4 listed here run from 2026-02-10 to 2026-08-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1819796 is on the EDGAR company page; the latest 10-K there is dated 2026-02-19 and the oldest filing in the recent index dates from 2020-08-03. Insider trades for GCM Grosvenor Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Giftify, inc. bullish and bearish analyst opinions

For “Giftify, inc. bullish and bearish analyst opinions”, the matching SEC registrant is GIFTIFY, INC., which trades as GIFT and files under Central Index Key 1760233. EDGAR puts it in the “Retail-Catalog & Mail-Order Houses” industry code with DE as its state or country of incorporation; its earlier registered name was RDE, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEF 14A filed 2026-10-20, across 147 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-18 by GIFTIFY, INC. (CIK 1760233) — source document:

As used in this Annual Report, the terms “we,” “us,” “our,” and the “Company” refer to Giftify, Inc., a Delaware corporation, and its consolidated subsidiaries. Giftify owns and operates Restaurant.com, a pioneer in the restaurant deal space and the nation’s largest restaurant-focused digital deals brand. Our profile fundamentally changed with the acquisition of CardCash Exchange, Inc. (“CardCash”) in December 2023. CardCash buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup. CardCash’s core service offering includes the buying and selling of gift cards from over 1,100 retailers, including Target, Home Depot, Starbucks, and TJ Maxx, among others. The acquisition and integration of CardCash have changed our financial position, market profile, and brand focus, and have also expanded our short-term search for additional business opportunities, both internal and external.

Financial trend for GIFTIFY, INC. from annual reports, periods 2023-12-29 to 2025-12-31: revenue went from $86.66 million (2023-12-29) to $83.18 million (2025-12-31), a change of -4.0%; net income (loss) went from -$124,545 (2023-12-29) to -$10.49 million (2025-12-31), a change of -8324.0%; total assets went from $39.76 million (2023-12-31) to $31.84 million (2025-12-31), a change of -19.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1760233, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures GIFTIFY, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on GIFTIFY, INC. (CIK 1760233) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-18. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 25 8-K or 6-K reports in GIFTIFY, INC.’s recent EDGAR index, the 4 listed here run from 2025-10-20 to 2026-08-07, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1760233 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-10 and the oldest filing in the recent index dates from 2018-11-28. Insider trades for GIFTIFY, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Gores holdings x, inc. bullish and bearish analyst opinions

For “Gores holdings x, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Gores Holdings X, Inc., which trades as none listed and files under Central Index Key 1897941. EDGAR puts it in the “Blank Checks” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-08-14, across 7 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on Gores Holdings X, Inc. (CIK 1897941) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

What kind of filer this is matters for “Gores holdings x, inc. bullish and bearish analyst opinions”: Gores Holdings X, Inc.’s EDGAR record from 2021-12-20 to 2026-08-14 consists only of RW filings; S-1 filings; SCHEDULE 13G/A filings; Schedule 13G ownership reports, filed when it held more than 5% of another company’s shares. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

The full record for CIK 1897941 is on the EDGAR company page and the oldest filing in the recent index dates from 2021-12-20. Insider trades for Gores Holdings X, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Graftech international eaf latest news october 2026

For “Graftech international eaf latest news october 2026”, the matching SEC registrant is GRAFTECH INTERNATIONAL LTD, which trades as EAF and files under Central Index Key 931148. EDGAR puts it in the “Electrical Industrial Apparatus” industry code with DE as its state or country of incorporation; its earlier registered name was UCAR INTERNATIONAL INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-10-23, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-13 by GRAFTECH INTERNATIONAL LTD (CIK 931148) — source document:

GrafTech International Ltd., founded in 1886 and incorporated in Delaware, is a leading manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. We believe that we have a competitive portfolio of low-cost ultra-high power (“UHP”) graphite electrode manufacturing facilities, with some of the highest capacity facilities in the world. We have graphite electrode manufacturing facilities in Calais, France; Pamplona, Spain; Monterrey, Mexico and St. Marys, Pennsylvania (idled in 2024). We are the only large-scale graphite electrode producer that is substantially vertically integrated into petroleum needle coke, our key raw material for graphite electrode manufacturing. This unique position provides us with a number of competitive advantages.

Financial trend for GRAFTECH INTERNATIONAL LTD from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.28 billion (2022-12-31) to $504.13 million (2025-12-31), a change of -60.7%; net income (loss) went from $382.96 million (2022-12-31) to -$219.84 million (2025-12-31), a change of -157.4%; total assets went from $1.60 billion (2022-12-31) to $1.03 billion (2025-12-31), a change of -35.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 931148, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures GRAFTECH INTERNATIONAL LTD did not tag for that period.

For the latest news, the fastest official source is the filing feed: GRAFTECH INTERNATIONAL LTD (CIK 931148) filed 134 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-23, and its overall latest filing is a 10-Q dated 2026-10-23. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 134 8-K or 6-K reports in GRAFTECH INTERNATIONAL LTD’s recent EDGAR index, the 4 listed here run from 2026-05-29 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 931148 is on the EDGAR company page; the latest 10-K there is dated 2026-02-13 and the oldest filing in the recent index dates from 2014-04-29. Insider trades for GRAFTECH INTERNATIONAL LTD appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Growhub ltd bullish and bearish analyst opinions

For “Growhub ltd bullish and bearish analyst opinions”, the matching SEC registrant is GrowHub Ltd, which trades as TGHL and files under Central Index Key 2024114. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-08-06, across 63 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-05-15 by GrowHub Ltd (CIK 2024114) — source document:

Operating and Financial Review and Prospects. 29 A. Operating Results. 29 Item 6. Directors, Senior Management and Employees. 40 A. Directors and Senior Management. 40 B. Compensation. 42 C. Board Practices. 42 D. Employees. 48 E. Share Ownership. 48 F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation. 48 Item 7. Major Shareholders and Related Party Transactions. 48 A. Major Shareholders. 49 B. Related Party Transactions. 50 C. Interests of Experts and Counsel. 50 Item 8. Financial Information. 50 A. Consolidated Statements and Other Financial Information. 50 B. Significant Changes. 50 Item 9. The Offer and Listing. 50 A. Offer and Listing Details. 50 B. Plan of Distribution. 50 C. Markets. 50 D. Selling Shareholders. 51 E. Dilution. 51 F. Expenses of the Issuer. 51 i Item 10.

Financial trend for GrowHub Ltd from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from 128,531 SGD (2023-12-31) to 83,032 SGD (2025-12-31), a change of -35.4%; net income (loss) went from -1,796,344 SGD (2023-12-31) to -17,200,587 SGD (2025-12-31), a change of -857.5%; total assets went from 4,291,357 SGD (2024-12-31) to 1,315,429 SGD (2025-12-31), a change of -69.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2024114, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures GrowHub Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on GrowHub Ltd (CIK 2024114) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-05-15. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 16 8-K or 6-K reports in GrowHub Ltd’s recent EDGAR index, the 4 listed here run from 2026-07-17 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2024114 is on the EDGAR company page; the latest 20-F there is dated 2026-05-15 and the oldest filing in the recent index dates from 2024-06-17. Insider trades for GrowHub Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Grupo aval acciones y valores s.a. bullish and bearish analyst opinions

For “Grupo aval acciones y valores s.a. bullish and bearish analyst opinions”, the matching SEC registrant is Grupo Aval Acciones Y Valores S.A., which trades as AVAL and files under Central Index Key 1504764. EDGAR puts it in the “Commercial Banks, NEC” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-01, across 550 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-17 by Grupo Aval Acciones Y Valores S.A. (CIK 1504764) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 114 A. Operating results 114 B. Liquidity and capital resources 147 C. Research and development, patents and licenses, etc. 151 D. Trend information 151 E. Critical Accounting Estimates 152 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 153 A. Directors and senior management 153 B. Compensation 157 C. Board practices 158 D. Employees 160 E. Share ownership 160 F. Disclosure of a registrant’s action to recover erroneously awarded compensation 161 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 161 A. Major shareholders 161 B. Related party transactions 161 C. Interests of experts and counsel 164 ITEM 8. FINANCIAL INFORMATION 164 A. Consolidated statements and other financial information 164 B. Significant changes 165 ITEM 9.

Financial trend for Grupo Aval Acciones Y Valores S.A. from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from 39,064,493,000,000 COP (2021-12-31) to 46,492,667,000,000 COP (2024-12-31), a change of +19.0%; net income (loss) went from 5,668,502,000,000 COP (2021-12-31) to 2,191,477,000,000 COP (2024-12-31), a change of -61.3%; total assets went from 366,903,925,000,000 COP (2021-12-31) to 327,859,383,000,000 COP (2024-12-31), a change of -10.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1504764, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Grupo Aval Acciones Y Valores S.A. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Grupo Aval Acciones Y Valores S.A. (CIK 1504764) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-17. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 488 8-K or 6-K reports in Grupo Aval Acciones Y Valores S.A.’s recent EDGAR index, the 4 listed here run from 2026-09-02 to 2026-10-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1504764 is on the EDGAR company page; the latest 20-F there is dated 2026-04-17 and the oldest filing in the recent index dates from 2011-03-07. Insider trades for Grupo Aval Acciones Y Valores S.A. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Grupo supervielle s.a. bullish and bearish analyst opinions

For “Grupo supervielle s.a. bullish and bearish analyst opinions”, the matching SEC registrant is Grupo Supervielle S.A., which trades as SUPV and files under Central Index Key 1517399. EDGAR puts it in the “Commercial Banks, NEC” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-06, across 452 filings on record. This is reference material, not trading advice.

Financial trend for Grupo Supervielle S.A. from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from 337,049,524,000 ARS (2021-12-31) to 857,585,866,000 ARS (2024-12-31), a change of +154.4%; net income (loss) went from -10,532,748,000 ARS (2021-12-31) to 104,569,295,000 ARS (2024-12-31), a change of +1092.8%; total assets went from 760,478,509,000 ARS (2021-12-31) to 4,505,842,884,000 ARS (2024-12-31), a change of +492.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1517399, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Grupo Supervielle S.A. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Grupo Supervielle S.A. (CIK 1517399) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-08. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 374 8-K or 6-K reports in Grupo Supervielle S.A.’s recent EDGAR index, the 4 listed here run from 2026-05-27 to 2026-08-24, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 452 recent EDGAR filings, Grupo Supervielle S.A. most often filed 6-K (374), 3 (21), 20-F (10), SC 13G/A (8). A selection from 2026-04-28 to 2026-10-06:

The full record for CIK 1517399 is on the EDGAR company page; the latest 20-F there is dated 2026-04-08 and the oldest filing in the recent index dates from 2015-09-08. Insider trades for Grupo Supervielle S.A. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

H&r century union corporation bullish and bearish analyst opinions

What this search refers to. “H&R Century Union Corporation” is a Taiwan-style company name; Taiwanese listed and OTC companies publish their reports on MOPS. Official source: mops.twse.com.tw.

No SEC filer could be matched to “H&r century union corporation bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “H&r century union corporation”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “century” (search terms considered: century, union, corporation).

A broader EDGAR full-text search for the shorter phrase “H&r century union” finds 46 filing documents; among the top 46, the filers mentioning it most are VANGUARD INTERNATIONAL EQUITY INDEX FUNDS (CIK 0000857489) (44); VANGUARD STAR FUNDS (CIK 0000736054) (2). Those are documents that name the term, not proof that any of these filers is the business in the search.

EDGAR’s company index has 189+ entities whose registered name contains the word “century”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “century” 469, “union” 479, “corporation” 486. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “century” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Harte hanks, inc. bullish and bearish analyst opinions

For “Harte hanks, inc. bullish and bearish analyst opinions”, the matching SEC registrant is HARTE HANKS INC, which trades as HHS and files under Central Index Key 45919. EDGAR puts it in the “Services-Direct Mail Advertising Services” industry code with DE as its state or country of incorporation; its earlier registered name was HARTE HANKS COMMUNICATIONS INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-15, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-17 by HARTE HANKS INC (CIK 45919) — source document:

Harte Hanks, Inc., together with its subsidiaries (“Harte Hanks,” “Company,” “we,” “our,” or “us”) is a glob al Business Experience Outsourcing company . We operate at the intersection of data, marketing , sales, customer care, fulfillment, and logistics integrating front office revenue growth and customer experience operations with back office execution to deliver measurable business outcomes. With offices in North America, Asia-Pacific and Europe, we serve leading global brands enabling them to design, activate and optimize the full customer and product lifecycle. We are the successor to a newspaper business started by Houston Harte and Bernard Hanks in Texas in the early 1920s. We were incorporated in Delaware on October 1, 197 0.

Financial trend for HARTE HANKS INC from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $206.28 million (2022-12-31) to $159.57 million (2025-12-31), a change of -22.6%; net income (loss) went from $36.78 million (2022-12-31) to -$811,000 (2025-12-31), a change of -102.2%; total assets went from $119.98 million (2022-12-31) to $91.83 million (2025-12-31), a change of -23.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 45919, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures HARTE HANKS INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on HARTE HANKS INC (CIK 45919) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-05-14, and the most recent 10-K annual report was filed 2026-03-17. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 206 8-K or 6-K reports in HARTE HANKS INC’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-09-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 45919 is on the EDGAR company page; the latest 10-K there is dated 2026-03-17 and the oldest filing in the recent index dates from 2009-04-09. Insider trades for HARTE HANKS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Helport ai company news 2026

For “Helport ai company news 2026”, the matching SEC registrant is Helport AI Ltd, which trades as HPAI, HPAIW and files under Central Index Key 2001699. EDGAR puts it in the “Services-Prepackaged Software” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-07-10 (this view begins at filings dated on or before 2024-11-12), across 62 filings on record. This is reference material, not trading advice.

More of the filing record for Helport AI Ltd (CIK 2001699), filings 2024-08-02 to 2024-12-04: DRS on 2024-12-04; SC 13G/A on 2024-11-12; 20-F on 2024-10-31; 20-F on 2024-08-09; CERT on 2024-08-02. Each form type has a fixed purpose under SEC rules, so the mix shows what kind of events the company has been reporting.

Company news that is material to investors in a Nasdaq-listed foreign issuer is normally furnished to the SEC on Form 6-K, often with a press release as Exhibit 99.1. Product announcements that are not material may appear only on the company’s website, so the two sources complement each other.

Hesai hsai latest news product factory earnings

For “Hesai hsai latest news product factory earnings”, the matching SEC registrant is Hesai Group, which trades as HSAI, HSIGF and files under Central Index Key 1861737. EDGAR puts it in the “General Industrial Machinery & Equipment, NEC” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-20, across 141 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-24 by Hesai Group (CIK 1861737) — source document:

We commenced our operations in October 2014 through Hesai Photonics Technology Co., Ltd., now known as Hesai Technology Co., Ltd., or Shanghai Hesai, a limited liability company incorporated under the laws of Chinese Mainland. Our initial focus was on high-performance laser sensors used in natural gas and other industries, but we shifted our primary business to the development, manufacturing and sales of LiDAR products in 2016. Since then, we have developed and produced a full range of LiDAR solutions and products for various applications in ADAS and Robotics. Through Shanghai Hesai, we established HESAI INC., a California corporation, and Shanghai Hesai Trade Co., Ltd., a Chinese Mainland limited liability company, in October 2017 and May 2019, respectively.

Financial trend for Hesai Group from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 0 CNY (2022-12-31) to 0 CNY (2023-12-31); net income (loss) went from -300,765,000 CNY (2022-12-31) to 435,880,000 CNY (2025-12-31), a change of +244.9%; total assets went from 3,839,396,000 CNY (2022-12-31) to 11,261,278,000 CNY (2025-12-31), a change of +193.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1861737, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Hesai Group did not tag for that period.

For reported results, Hesai Group’s (CIK 1861737) EDGAR record shows no 10-Q in the recent window and its latest annual report (20-F) 2026-04-24.

For the latest news, the fastest official source is the filing feed: Hesai Group (CIK 1861737) filed 58 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-20, and its overall latest filing is a 6-K dated 2026-10-20. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 58 8-K or 6-K reports in Hesai Group’s recent EDGAR index, the 4 listed here run from 2026-08-28 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1861737 is on the EDGAR company page; the latest 20-F there is dated 2026-04-24 and the oldest filing in the recent index dates from 2021-07-02. Insider trades for Hesai Group appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Imagenebio inc bullish and bearish analyst opinions

For “Imagenebio inc bullish and bearish analyst opinions”, the matching SEC registrant is ImageneBio, Inc., which trades as IMA and files under Central Index Key 1835579. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Ikena Oncology, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-08-17, across 336 filings on record. This is reference material, not trading advice.

Financial trend for ImageneBio, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $15.62 million (2022-12-31) to $800,000 (2025-12-31), a change of -94.9%; net income (loss) went from -$68.77 million (2022-12-31) to -$45.35 million (2025-12-31), a change of +34.1%; total assets went from $172.26 million (2022-12-31) to $152.98 million (2025-12-31), a change of -11.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1835579, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures ImageneBio, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on ImageneBio, Inc. (CIK 1835579) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-05, and the most recent 10-K annual report was filed 2026-03-10. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 53 8-K or 6-K reports in ImageneBio, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-17 to 2026-08-05, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 336 recent EDGAR filings, ImageneBio, Inc. most often filed 4 (85), 8-K (53), 3 (29), 10-Q (17). A selection from 2026-08-11 to 2026-08-17:

The full record for CIK 1835579 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2021-01-08. Insider trades for ImageneBio, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Immunotech biopharm ltd bullish and bearish analyst opinions

The legal-form ending in “Immunotech biopharm ltd” is the clue: “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. A company of that kind reports in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), so the place to read its annual report and announcements is that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) — www.hkexnews.hk.

No SEC filer could be matched to “Immunotech biopharm ltd bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Immunotech biopharm ltd” appears in 328+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “immunotech” (search terms considered: immunotech, biopharm).

In the 100 most relevant full-text hits returned for “Immunotech biopharm ltd”, filings range from 2020-10-27 to 2026-06-25. The filers whose documents mention it most often are ETF Series Solutions (CIK 0001540305) (30 hits); TIAA-CREF FUNDS (CIK 0001084380) (25 hits); iSHARES TRUST (CIK 0001100663) (12 hits); SPDR INDEX SHARES FUNDS (CIK 0001168164) (12 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 2 entities whose registered name contains the word “immunotech”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “immunotech” 2, “biopharm” 14. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “immunotech”: AIM IMMUNOTECH INC. (CIK 946644), IMMUNOTECH LABORATORIES, INC. (CIK 1137117); containing “biopharm”: BENEVIR BIOPHARM, INC. (CIK 1626108), BIOPHARM ASIA, INC. (CIK 1080908), BIOPHARM HOLDING CORP. (CIK 1546286). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: analyst views on “immunotech” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Immunovant

For “Immunovant”, the matching SEC registrant is Immunovant, Inc., which trades as IMVT and files under Central Index Key 1764013. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Health Sciences Acquisitions Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-23, across 647 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-05-20 by Immunovant, Inc. (CIK 1764013) — source document:

Immunovant, Inc. (“Immunovant,” “we” or the “Company”) is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Our focus is on developing IMVT-1402 (imeroprubart), a potentially best-in-class inhibitor of the neonatal fragment crystallizable receptor (“FcRn”), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (“IgG”) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. We believe that FcRn inhibition has broad therapeutic and commercial potential to address pathogenic IgG-mediated autoimmune diseases in several therapeutic areas, including but not limited to, endocrinology, neurology, rheumatology and dermatology.

Financial trend for Immunovant, Inc. from annual reports, periods 2023-03-31 to 2026-03-31: net income (loss) went from -$210.96 million (2023-03-31) to -$505.61 million (2026-03-31), a change of -139.7%; total assets went from $405.84 million (2023-03-31) to $957.01 million (2026-03-31), a change of +135.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1764013, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Immunovant, Inc. did not tag for that period.

Immunovant, Inc. has 647 filings in its recent EDGAR index, including 7 annual reports and 23 quarterly reports; its newest filing is a 4 from 2026-10-23.

Current reports. Of the 84 8-K or 6-K reports in Immunovant, Inc.’s recent EDGAR index, the 4 listed here run from 2026-02-06 to 2026-09-03, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1764013 is on the EDGAR company page; the latest 10-K there is dated 2026-05-20 and the oldest filing in the recent index dates from 2019-01-23. Insider trades for Immunovant, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Imunon, inc. bullish and bearish analyst opinions

For “Imunon, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Imunon, Inc., which trades as IMNN and files under Central Index Key 749647. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was CELSION CORP. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-21, across 1005 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by Imunon, Inc. (CIK 749647) — source document:

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 45 Market for Our Common Stock 45 Record Holders 45 Dividend Policy 45 Performance Graph 45 Issuer Purchases of Equity Securities 45 ITEM 6. RESERVED 45 ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 45 Overview 46 Business Plan 46 Financing Overview 47 Critical Accounting Policies and Estimates 49 Results of Operations 50 Financial Condition, Liquidity and Capital Resources 52 Off-Balance Sheet Arrangements 52 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 52 ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 52 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 53 ITEM 9A. CONTROLS AND PROCEDURES 53 ITEM 9B. OTHER INFORMATION 53 ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 53 PART III ITEM 10.

Financial trend for Imunon, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue was tagged only for 2022-12-31 at $500,000; net income (loss) went from -$35.90 million (2022-12-31) to -$14.50 million (2025-12-31), a change of +59.6%; total assets went from $43.98 million (2022-12-31) to $12.29 million (2025-12-31), a change of -72.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 749647, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Imunon, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Imunon, Inc. (CIK 749647) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 226 8-K or 6-K reports in Imunon, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-11 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 749647 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2011-05-31. Insider trades for Imunon, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Imxi wu merger

A merger query for money-transfer companies International Money Express and Western Union. What follows is each company’s own disclosure trail as EDGAR showed it on Oct 25, 2026.

International Money Express, Inc. (IMXI; services-business services, nec, incorporated in DE) — EDGAR lists the 8-K of 2026-10-02 covering 8.01 (other events); the 8-K of 2025-12-09 covering 5.07 (submission of matters to a vote of security holders). Year to 2019-12-31: annual sales of $319.60 million, net result $19.61 million (10-K, 2020-03-11).

Western Union CO (WU; services-business services, nec, incorporated in DE) — EDGAR lists the 8-K of 2026-10-02 covering 8.01 (other events); the 8-K of 2026-08-14 covering 7.01 (regulation fd disclosure), 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2025-12-31: annual sales of $4.05 billion, net result $499.60 million (10-K, 2026-02-20).

Item 2.01 — completion of an acquisition or disposition of assets — appears this many times per company: IMXI 1 (latest 2018-08-01), WU 1 (latest 2019-05-09).

A merger between a money-transfer operator and Western Union would be disclosed through an 8-K under Item 1.01 for the merger agreement, a merger proxy for shareholders, and later an 8-K under Item 2.01 when it closed. Both companies’ filing indexes are the place to confirm the deal’s status, because money-transmitter licences in many states also require regulatory approvals before closing.

Intchains group limited bullish and bearish analyst opinions

For “Intchains group limited bullish and bearish analyst opinions”, the matching SEC registrant is Intchains Group Ltd, which trades as ICG and files under Central Index Key 1895597. EDGAR puts it in the “Semiconductors & Related Devices” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-18 (this view begins at filings dated on or before 2026-05-07), across 106 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-13 by Intchains Group Ltd (CIK 1895597) (passage 2, continuing from the earlier excerpt) — source document:

In February 2022, Intchains Global acquired 100% equity interest in Intchains Pte. Ltd., a private limited company incorporated in Singapore, for the purpose of holding our planned business in Singapore. Following the incorporation of Intchains BVI, Intchains Technology (Hongkong) Limited, or Intchains HK, was incorporated in Hong Kong in July 2021 as a wholly-owned subsidiary of Intchains BVI. In September 2021, Intchains HK established Jerryken Intelligent Technology (Shanghai) Co., Ltd., or WFOE, as a wholly foreign owned entity in the PRC. In October 2021, Golden Stone Hong Kong Holding Limited, a then independent third party which is wholly owned by Mr. Zhaoyang Ma who is a principal shareholder, acquired 1% equity interest in Shanghai Intchains, upon completion of which, Shanghai Intchains became a sino-foreign equity joint venture.

Financial trend for Intchains Group Ltd from annual reports, periods 2020-12-31 to 2021-12-31: revenue went from 54,603,000 CNY (2020-12-31) to 631,838,000 CNY (2021-12-31), a change of +1057.1%; net income (loss) went from 8,247,000 CNY (2020-12-31) to 450,144,000 CNY (2021-12-31), a change of +5358.3%; total assets was tagged only for 2021-12-31 at 611,260,000 CNY. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1895597, tags Assets, NetIncomeLoss, Revenues; 2 periods shown, dashes mark figures Intchains Group Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Intchains Group Ltd (CIK 1895597) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-13. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 27 8-K or 6-K reports in Intchains Group Ltd’s recent EDGAR index, the 4 listed here run from 2025-11-13 to 2026-04-17, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1895597 is on the EDGAR company page; the latest 20-F there is dated 2026-04-13 and the oldest filing in the recent index dates from 2022-01-18. One example from this record is the 4/A filed 2026-08-19 (document). Insider trades for Intchains Group Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Interlink communication public company limited bullish and bearish analyst opinions

“Public Company Limited” is the legal form Thai law requires for companies listed on SET or mai. The name “Interlink communication public company limited” therefore points to a company organised in Thailand, and its official disclosures are on the Stock Exchange of Thailand (SET) company pages and the SEC Thailand filing system (www.set.or.th), not on EDGAR.

No SEC filer could be matched to “Interlink communication public company limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Interlink communication public company limited” appears in 25 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “interlink” (search terms considered: interlink, communication, public).

A broader EDGAR full-text search for the shorter phrase “Interlink communication public” finds 52 filing documents; among the top 52, the filers mentioning it most are Dimensional ETF Trust (CIK 0001816125) (20); DFA INVESTMENT DIMENSIONS GROUP INC (CIK 0000355437) (10); THAI CAPITAL FUND INC (CIK 0000861865) (8). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 25 most relevant full-text hits returned for “Interlink communication public company limited”, filings range from 2008-07-15 to 2025-03-28. The filers whose documents mention it most often are Dimensional ETF Trust (CIK 0001816125) (20 hits); SEI INSTITUTIONAL INVESTMENTS TRUST (CIK 0000939934) (3 hits); THAI CAPITAL FUND INC (CIK 0000861865) (2 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 14 entities whose registered name contains the word “interlink”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “interlink” 14, “communication” 100, “public” 466. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “interlink” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Invivyd

For “Invivyd”, the matching SEC registrant is Invivyd, Inc., which trades as IVVD and files under Central Index Key 1832038. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Adagio Therapeutics, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-29, across 448 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-05 by Invivyd, Inc. (CIK 1832038) — source document:

Recipients should not be currently infected with or have had a known recent exposure to an individual infected with SARS-CoV-2. The emergency use of PEMGARDA is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act (“FDCA”), 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization revoked sooner. PEMGARDA is authorized for use only when the combined national frequency of variants with substantially reduced susceptibility to PEMGARDA is less than or equal to 90%, based on available information including variant susceptibility to PEMGARDA and national variant frequencies.

Financial trend for Invivyd, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $0 (2023-12-31) to $53.43 million (2025-12-31); net income (loss) went from -$241.32 million (2022-12-31) to -$52.49 million (2025-12-31), a change of +78.2%; total assets went from $383.17 million (2022-12-31) to $276.88 million (2025-12-31), a change of -27.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1832038, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Invivyd, Inc. did not tag for that period.

Invivyd, Inc. has 448 filings in its recent EDGAR index, including 5 annual reports and 16 quarterly reports; its newest filing is a 8-K from 2026-09-29.

Current reports. Of the 100 8-K or 6-K reports in Invivyd, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-24 to 2026-09-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1832038 is on the EDGAR company page; the latest 10-K there is dated 2026-03-05 and the oldest filing in the recent index dates from 2020-11-12. Insider trades for Invivyd, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Iveda solutions, inc. bullish and bearish analyst opinions

For “Iveda solutions, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Iveda Solutions, Inc., which trades as IVDA, IVDAW and files under Central Index Key 1397183. EDGAR puts it in the “Services-Prepackaged Software” industry code with NV as its state or country of incorporation; its earlier registered name was Iveda Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEF 14A filed 2026-10-16, across 506 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by Iveda Solutions, Inc. (CIK 1397183) — source document:

Iveda Solutions, Inc. (“Iveda”, or the “Company”) was incorporated in Nevada as Charmed Homes, Inc. in June 2006. On October 15, 2009, IntelaSight, d/b/a Iveda, a Washington corporation, became a wholly owned subsidiary of the Company. In December 2010, IntelaSight merged with and into the Company and the Company became the surviving company. Iveda offered the first cloud hosting of streaming and recorded video from security cameras for its customers and real-time remote surveillance service utilizing intervention specialists to watch our customers’ cameras in real time, 24/7. In April 2011, Iveda completed the acquisition of the Taiwan-based company Sole-Vision Technologies (doing business as Iveda Taiwan). Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing.

Financial trend for Iveda Solutions, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue was tagged only for 2022-12-31 at $4.47 million; net income (loss) went from -$3.35 million (2022-12-31) to -$3.20 million (2025-12-31), a change of +4.4%; total assets went from $9.86 million (2022-12-31) to $6.43 million (2025-12-31), a change of -34.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1397183, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Iveda Solutions, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Iveda Solutions, Inc. (CIK 1397183) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 70 8-K or 6-K reports in Iveda Solutions, Inc.’s recent EDGAR index, the 4 listed here run from 2025-12-10 to 2026-09-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1397183 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2007-04-20. Insider trades for Iveda Solutions, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

John b. sanfilippo & son, inc. bullish and bearish analyst opinions

For “John b. sanfilippo & son, inc. bullish and bearish analyst opinions”, the matching SEC registrant is JOHN B SANFILIPPO & SON INC, which trades as none listed and files under Central Index Key 889867. EDGAR puts it in the “no SIC description” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SC 13G/A filed 2017-02-10, across 17 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on JOHN B SANFILIPPO & SON INC (CIK 889867) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

It helps to know what sort of filer sits behind “John b. sanfilippo & son, inc. bullish and bearish analyst opinions”: JOHN B SANFILIPPO & SON INC’s EDGAR record from 2005-02-10 to 2017-02-10 consists only of SC 13G/A filings; Schedule 13G ownership reports, filed when it held more than 5% of another company’s shares. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

Updated Oct 25, 2026 ET